TRUALTNSETruAlt Bioenergy LimitedMinimalNeutral
Announced Fri, 15 May · 12:50 IST

Monitoring Agency Report issued by Crisil Ratings Limited, Monitoring Agency for the quarter ended March 31, 2026.

TRUALT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹450.00
prior close
₹457.65
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2+0.1+0.1-0.7+2.7+6.5+5.8+9.9+9.5+15.1+9.4-5.4
Up moveDown movePending
AI summary

Crisil Ratings Limited, the monitoring agency for TruAlt Bioenergy's IPO, has submitted its Q4 FY2026 report on utilization of Rs 750 crore raised in the September 2025 IPO. Of the gross proceeds, Rs 720.21 crore (96%) has been deployed as of March 31, 2026, with Rs 29.79 crore remaining in monitoring and public offer accounts. Capital expenditure for the multi-feed stock operations project saw a minor delay—Rs 140.14 crore of the Rs 150.68 crore allocation was utilized due to pending vendor invoices, though the company has stated the unutilized Rs 10.54 crore will be deployed upon receipt. Working capital (Rs 425 crore) and general corporate purposes (Rs 81.36 crore) were fully utilized. No material deviations from the offer document were observed.

Likely market impact

The IPO proceeds are largely on track with no major deviations reported. The minor delay in capital expenditure deployment is administrative in nature and not a structural concern. Shareholders can note that the ethanol expansion project is progressing as intended.